← All stocks

CNS Pharmaceuticals, Inc.

CNSP Net buying
CIK 0001729427 #5284 in the set updated 20 Sep 2026
Bought (120 mo)
$502.58K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$133.11K
$133.11K on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 17 sales
Net
+$369.47K
+$502.58K against sales at will

By person

9 insiders · 32 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Downs Christopher
Chief Financial Officer
$363.67K (6)
+$363.67K
103,438
$495.36K
Priebe Waldemar
10% owner
$133.11K (17) scheduled
−$133.11K
156,807
$750.95K
−91.0%
Climaco John M
Chief Executive Officer
$65.35K (3)
+$65.35K
215,676
$1.03M
Charles Faith L.
Director
$34.00K (1)
+$34.00K
7,100
$34.00K
Gumulka Jerzy
Director
$19.56K (3)
+$19.56K
43,006
$205.96K
Fisher Michal
Director
$10.00K (1)
+$10.00K
2,000
$9.58K
Evans Carl Anthony
Director
$10.00K (1)
+$10.00K
33,458
$160.23K
Keyes Jeffry R.
Director
11,100
$53.16K
Levin Rami
CEO and President
4,750
$22.75K
−50.0%

No percentages here. This company's share count has moved by a factor of 100.0 over the window, from 574,580 to 57,486,706 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 68
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 17
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 1,590,238
History held since 13 Nov 2019